Clinical trial

US Benchmarking Clinical Study

NCT07215715

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-09-16

PhaseN/A

Study timeline

Study start (actual)2025-09-16Date precision: day

Registry last updated2025-10-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HFpEF - Heart Failure With Preserved Ejection Fractionunresolved

HFmrEFunresolved

ATTR-CM (Transthyretin Amyloid Cardiomyopathy)unresolved

Left Ventricular Hypertrophyunresolved

Cardiac Amyloidosisunresolved

Interventions

Sponsors & collaborators

eMyosound SASlead sponsor

Massachusetts General Hospitalcollaborator

Brigham and Women's Hospitalcollaborator

Boston Medical Centercollaborator

Mapped research locations

BostonMassachusetts, United States3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07215715 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.